Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akebia Therapeutics (AKBA) Cash from Investing Activities (2016 - 2026)

Akebia Therapeutics has reported Cash from Investing Activities over the past 9 years, most recently at -$7.9 million for Q4 2025.

  • Quarterly Cash from Investing Activities fell 393750.0% to -$7.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$7.9 million through Dec 2025, down 23918.18% year-over-year, with the annual reading at -$7.9 million for FY2025, 23918.18% down from the prior year.
  • Cash from Investing Activities was -$7.9 million for Q4 2025 at Akebia Therapeutics, down from -$77000.0 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $20.0 million in Q2 2021 and troughed at -$7.9 million in Q4 2025.
  • The 4-year median for Cash from Investing Activities is -$15500.0 (2024), against an average of $3.2 million.
  • Year-over-year, Cash from Investing Activities skyrocketed 8039.18% in 2021 and then tumbled 393750.0% in 2025.
  • A 4-year view of Cash from Investing Activities shows it stood at $20.0 million in 2021, then tumbled by 100.57% to -$114000.0 in 2022, then soared by 98.25% to -$2000.0 in 2024, then tumbled by 393750.0% to -$7.9 million in 2025.
  • Per Business Quant, the three most recent readings for AKBA's Cash from Investing Activities are -$7.9 million (Q4 2025), -$77000.0 (Q3 2025), and -$126000.0 (Q2 2025).